title: The new ParaDIgm: IgM from bench to clinic: November 15-16, 2011, Frankfurt, Germany.
abstract: The inaugural IgM event entitled "The new ParaDIgm: IgM from bench to clinic" brought together the increasingly active and growing IgM antibody community to discuss recent advances and challenges facing the discovery and development of IgM antibody therapies and technologies. Researchers, clinicians and biomanufacturing experts delivered 21 talks on the basic science and isolation of IgM, upstream and downstream development, and formulation and clinical development of the molecules. Participants networked around topics aimed at exploring the full potential of IgM antibodies. The meeting was held at DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e. V. (Society for Chemical Engineering and Biotechnology), a non-profit scientific and technical society based in Frankfurt am Main, Germany. The meeting was sponsored by Patrys, Laureate Biopharma, Bio-Rad Laboratories, BIA Separations, Percivia and the Bio Affinity Company (BAC). The second New ParaDIgm: IgM from bench to clinic meeting, will be held on April 23-24, 2013 in Frankfurt, Germany.
authors.affiliation: Bio-Rad Laboratories Inc., Hercules, CA, USA. Sherif_Hanala@bio-rad.com
authors.forename: Sherif
authors.initials: S
authors.lastname: Hanala
mesh_terms: D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000276:immunology* / Q000302:isolation & purification / Q000627:therapeutic use; D001709:Biotechnology / Q000379:methods*; D002460:Cell Line; D002986:Clinical Trials as Topic; D006801:Humans; D007075:Immunoglobulin M / Q000737:chemistry / Q000276:immunology* / Q000302:isolation & purification / Q000627:therapeutic use; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D007075:Immunoglobulin M